Schedule 13G ownership disclosure

ABIVAX SA SPONSORED ADS

Ordinary Shares, nominal value 0.01 euro per share · CUSIP: 00370M103

Event date: 2025-09-30

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Venrock Healthcare Capital Partners III, L.P.

    Shares: 576,729.00 · Class: 0.8%

  • VHCP Co-Investment Holdings III, LLC

    Shares: 576,729.00 · Class: 0.8%

  • Venrock Healthcare Capital Partners EG, L.P.

    Shares: 576,729.00 · Class: 0.8%

  • VHCP Management III, LLC

    Shares: 576,729.00 · Class: 0.8%

  • VHCP Management EG, LLC

    Shares: 576,729.00 · Class: 0.8%

  • Nimish Shah

    Shares: 576,729.00 · Class: 0.8%

  • Bong Y. Koh

    Shares: 576,729.00 · Class: 0.8%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001738048-25-000014
Form type
SCHEDULE 13G/A
Filer
Abivax S.A.
CIK
CIK 1956827
Filed
Nov 14, 2025
Reporting period
Sep 30, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub